Series A Financing Round Lays Foundation For International Growth Of Digital Cancer Therapeutics Mika
Round Type
Series A
ChinaInformation TechnologyEnergySustainabilityFinancial ServicesData And AnalyticsEducationLending And InvestmentsDescription
Berlin-based digital health company Fosanis, the developer of Mika, Germany's first prescription DTx for all oncological indications, closed a series A funding round of more than 10 million EUR. Besides existing shareholders such as Ananda Impact Ventures, three new investors joined in the latest financing round: lead investor Swiss company Debiopharm Innovation Fund, Ship2B Ventures from Spain and venture capital firm Equity Pitcher.
Who to call at Aria, and when
A new round usually means Aria is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aria raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aria, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aria. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aria raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAria raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.